Short and long-term mortality of patients presenting with bleeding events to the Emergency Department

被引:5
作者
Conti, Alberto [1 ]
Renzi, Noemi [1 ]
Molesti, Daniele [1 ]
Bianchi, Simone [1 ]
Bogazzi, Irene [1 ]
Bongini, Giada [1 ]
Pepe, Giuseppe [2 ]
Frosini, Fabiana [2 ]
Bertini, Alessio [3 ]
Santini, Massimo [4 ,5 ]
机构
[1] Apuane Gen Hosp, Emergency Dept, North West Dist Tuscany HealthCare, Massa Carrara, Italy
[2] Versilia & San Luca Gen Hosp, Emergency Dept, North West Dist Tuscany HealthCare, Viareggio Lucca, Italy
[3] Spedali Riuniti Livorno, Emergency Dept, Tuscany HealthCare, Livorno, Italy
[4] Cisanello Gen Hosp, North West Dist Tuscany HealthCare, Pisa, Italy
[5] Univ Pisa, Emergency Dept, Pisa, Italy
关键词
Bleeding; Antiplatelets; Anticoagulants; Prognosis; Emergency department; ORAL ANTICOAGULANTS; ATRIAL-FIBRILLATION; WARFARIN; RIVAROXABAN; GUIDELINES; SAFETY; METAANALYSIS; DABIGATRAN; MANAGEMENT; EFFICACY;
D O I
10.1016/j.ajem.2017.06.025
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Death of patients presenting with bleeding events to the Emergency Department still represent a major problem. We sought to analyze clinical characteristics associated with worse outcomes including short- and long-term death, beyond antithombotic treatment strategy. Methods: Patients presenting with any bleeding events during 2016-2017 years were enrolled. Clinical parameters, site of bleeding, major bleeding, ongoing anti-thrombotic treatment strategy and death were collected. Hard 5: 1 propensity score matching was performed to adjust dead patients in baseline characteristics. Endpoints were one-month and one-year death. Results: Out of 166,000 visits to the Emergency Department, 3.050 patients (1.8%) were enrolled and eventually 429 were analyzed after propensity. Overall, anticoagulants or antiplatelets were given to 234(54%). Major bleeding account for 111(26%) patients, without differences between those taking anticoagulants or antiplatelets versus others. Death at one-month and one-year was 26(6%) and 72(17%), respectively. Independent predictors of one-month death were major bleeding (Odds Ratio, OR 26, p < 0.001), female gender (OR 7, p < 0.001) and white blood cells (OR 1.2, p = 0.01); of one-year were major bleeding (OR 7, p < 0.001), age (OR 1.1, p < 0.001) and female gender (OR 2.3, p = 0.043). Of note, death rate of gastrointestinal and intracranial bleeding where higher than others (p < 0.001). Overall mortality was approximately 40% on one-month; 60% in older patients and 80% in female gender with CHA(2)D(2)VASC-score >= 2. Receiver operator characteristics analysis showed larger areas for major bleeding and age (0.75 and 0.72, respectively) over others; p < 0.05 on C-statistic. Conclusions: In patients with bleeding events, death rate was driven by major bleeding on short-term and older age on long-term. Among dead patients mortality was approximately 40% on one-month; 60% in older patients, and 80% in female gender. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:1867 / 1872
页数:6
相关论文
共 20 条
[1]   Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study [J].
Abraham, Neena S. ;
Singh, Sonal ;
Alexander, G. Caleb ;
Heien, Herbert ;
Haas, Lindsey R. ;
Crown, William ;
Shah, Nilay D. .
BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
[2]  
Amsterdam EA, 2014, J AM COLL CARDIOL, V64, pE139, DOI [10.1016/j.jacc.2014.09.017, 10.1161/CIR.0000000000000134, 10.1016/j.jacc.2014.10.011, 10.1016/j.jacc.2014.09.016]
[3]   Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life [J].
Becattini, Cecilia ;
Franco, Laura ;
Beyer-Westendorf, Jan ;
Masotti, Luca ;
Nitti, Cinzia ;
Vanni, Simone ;
Manina, Giorgia ;
Cattinelli, Sergio ;
Cappelli, Roberto ;
Sbrojavacca, Rodolfo ;
Pomero, Fulvio ;
Marten, Sandra ;
Agnelli, Giancarlo .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 227 :261-266
[4]   National surveillance of emergency department visits for outpatient adverse drug events [J].
Budnitz, Daniel S. ;
Pollock, Daniel A. ;
Weidenbach, Kelly N. ;
Mendelsohn, Aaron B. ;
Schroeder, Thomas J. ;
Annest, Joseph L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (15) :1858-1866
[5]   Emergency Hospitalizations for Adverse Drug Events in Older Americans [J].
Budnitz, Daniel S. ;
Lovegrove, Maribeth C. ;
Shehab, Nadine ;
Richards, Chesley L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (21) :2002-2012
[6]  
Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]
[7]   New Oral Anticoagulants and the Risk of Intracranial Hemorrhage Traditional and Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials of New Oral Anticoagulants in Atrial Fibrillation [J].
Chatterjee, Saurav ;
Sardar, Partha ;
Biondi-Zoccai, Giuseppe ;
Kumbhani, Dharam J. .
JAMA NEUROLOGY, 2013, 70 (12) :1486-1490
[8]   New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysis [J].
Holster, I. Lisanne ;
Valkhoff, Vera E. ;
Kuipers, Ernst J. ;
Tjwa, Eric T. T. L. .
GASTROENTEROLOGY, 2013, 145 (01) :105-+
[9]   Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients [J].
Laliberte, Francois ;
Cloutier, Michel ;
Nelson, Winnie W. ;
Coleman, Craig I. ;
Pilon, Dominic ;
Olson, William H. ;
Damaraju, C. V. ;
Schein, Jeffrey R. ;
Lefebvre, Patrick .
CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (07) :1317-1325
[10]   Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: Predictors, prognostic significance, and paradigms for reducing risk [J].
Manoukian, Steven V. ;
Voeltz, Michele D. ;
Eikelboom, John .
CLINICAL CARDIOLOGY, 2007, 30 (10) :24-34